Questionable antipsychotic prescribing remains common, despite serious risks

JAMA. 2010 Apr 28;303(16):1582-4. doi: 10.1001/jama.2010.453.
No abstract available

Publication types

  • News

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Humans
  • Off-Label Use
  • Practice Patterns, Physicians'*
  • Psychiatry
  • United States
  • United States Food and Drug Administration

Substances

  • Antipsychotic Agents